SciSparc Ltd.
SPRC · Pharmaceutical Preparations · EDGAR filings ↗
Reference price $10.00 — last insider sale, 2026-06-01 (estimated from the dated SEC Form 4 price — not a live quote)
Grade
C55gen composite 27pct→55
Notable findings
- No interest coverageInterest coverage -20.73 (cannot cover interest)
Key metrics
Return on equity
-83.6%
Return on assets
-72.2%
ROIC
-64.7%
Interest coverage
-20.7×
Current ratio
5.4×
Tangible book value
$7M
Cash & investments
$2M
Leadership & compensation
| Name | Role | Latest total comp |
|---|---|---|
| Shrem Itschak | Director | — |
Officers & directors from SEC filings (Form 4 + DEF 14A proxy); compensation is the latest reported fiscal year.
Insider transactions · last 6 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-01 | Shrem Itschak | Sell | 462 | $10.00 |
All non-derivative Form 4 activity (SEC), newest first.
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 20-F | 2026-04-29 | 2025-12-31 | 0001213900-26-049322 ↗ |
| 20-F | 2025-04-24 | 2024-12-31 | 0001213900-25-035115 ↗ |
| 20-F | 2024-04-01 | 2023-12-31 | 0001213900-24-028859 ↗ |
| 20-F | 2023-05-01 | 2022-12-31 | 0001213900-23-034606 ↗ |
| 20-F | 2022-04-28 | 2021-12-31 | 0001213900-22-022294 ↗ |
| 20-F | 2021-03-30 | 2020-12-31 | 0001213900-21-018407 ↗ |
| 20-F | 2020-06-15 | 2019-12-31 | 0001213900-20-014990 ↗ |
| 20-F | 2019-05-15 | 2018-12-31 | 0001213900-19-008868 ↗ |
| 20-F | 2018-04-30 | 2017-12-31 | 0001213900-18-005176 ↗ |
| 20-F | 2017-05-01 | 2016-12-31 | 0001213900-17-004433 ↗ |